Revolutionizing Precision Medicine
Vin Singh, Founder & CEO of BullFrog AI (NASDAQ: BFRGW), recently shared BullFrog’s ambitious vision with Benzinga.
BullFrog AI has unveiled its bfLEAP platform, a game-changing technology poised to disrupt the field of precision medicine. The platform harnesses the power of predictive analytics to expedite all facets of drug development, potentially rewriting the rules of the game.
In a major coup, the company has inked a partnership with the esteemed Johns Hopkins University to secure an exclusive license for its AI technology.
Featured photo by Louis Reed on Unsplash.
This post contains sponsored content. This content is for informational purposes only and not intended to be investing advice.